Literature DB >> 1788266

Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain).

S C Lo1, C L Buchholz, D J Wear, R C Hohm, A M Marty.   

Abstract

The newly recognized human pathogenic mycoplasma M. fermentans (incognitus strain) causes a fatal systemic infection in experimental monkeys, infects patients with AIDS, and apparently is associated with a fatal disease in previously healthy non-AIDS patients. An apparently immunocompetent male who lacked evidence of HIV infection developed fever, malaise, progressive weight loss, and diarrhea and had extensive tissue necrosis involving liver and spleen. M. fermentans (incognitus strain) was centered at the advancing margins of these necrotizing lesions. Following the treatment of 300 mg doxycycline per day for 6 weeks, he recovered fully. He has no fever or diarrhea, and his abnormal liver function tests have returned to normal. He regained all lost strength and 14 kg of lost weight and has remained disease free for more than 1 year.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788266

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

Authors:  M M Hayes; H H Foo; J Timenetsky; S C Lo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

2.  In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.

Authors:  M M Hayes; H H Foo; H Kotani; D J Wear; S C Lo
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 3.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

4.  Isolation and characterization of two novel bacteria Afipia cberi and Mesorhizobium hominis from blood of a patient afflicted with fatal pulmonary illness.

Authors:  Shyh-Ching Lo; Bingjie Li; Guo-Chiuan Hung; Haiyan Lei; Tianwei Li; Jing Zhang; Kenjiro Nagamine; Shien Tsai; Mark J Zucker; Ludmilla Olesnicky
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.